Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity. (Q51143927)
Jump to navigation
Jump to search
scientific article published on 4 November 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity. |
scientific article published on 4 November 2013 |
Statements
Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity (English)
Shimon Slavin
4 November 2013